Cardiovascular toxicity of cryopreserved cord blood cell infusion

Bone Marrow Transplantation

Volumn 41, Issue 10, 2008, Pages 861-865

  Konuma, T ^a   Ooi, Jun ^a   Takahashi, S ^a   Tomonari, A ^a   Tsukada, N ^a   Kobayashi, T ^a   Sato, A ^a   Kato, S ^a   Kasahara, S ^a   Ebihara, Y ^a   Nagamura Inoue, T ^a   Tsuji, K ^a   Tojo, A ^a   Asano, S ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACLARUBICIN; ANTHRACYCLINE; ANTIHYPERTENSIVE AGENT; ANTINEOPLASTIC AGENT; BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; DAUNORUBICIN; DOXORUBICIN; FLUDARABINE; HYDROCORTISONE; HYDROXYZINE; IDARUBICIN; METHOTREXATE; MITOXANTRONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ADOLESCENT; ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; BRADYCARDIA; CARDIOVASCULAR SYMPTOM; CLINICAL ARTICLE; CLINICAL TRIAL; CRYOPRESERVATION; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOLOGIC MALIGNANCY; HUMAN; HUMAN CELL; INCIDENCE; MALE; OUTCOME ASSESSMENT; OXYGEN SATURATION; PATIENT SAFETY; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; SYSTOLIC HYPERTENSION; THAWING; UMBILICAL CORD BLOOD; VEIN CATHETERIZATION; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; BRADYCARDIA; CARDIAC COMPLEXES, PREMATURE; CORD BLOOD STEM CELL TRANSPLANTATION; CRYOPRESERVATION; FEMALE; HEMATOLOGIC NEOPLASMS; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 44449128280     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1705993     Document Type: Article

References (24)

1. Rubinstein P, Carrier C, Scaradavou A, Kurtzberg J, Adamson J, Migliaccio AR et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med 1999; 339: 1565-1577.
2. Laughlin MJ, Eapen M, Rubinstein P, Wagner JE, Zhang MJ, Champlin RE et al. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N Engl J Med 2004; 351: 2265-2275.
3. Rocha V, Labopin M, Sanz G, Arcese W, Schwerdtfeger R, Bosi A et al Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. N Engl J Med 2004; 351 2276-2285.
4. Takahashi S, Iseki T, Ooi J, Tomonari A, Takasugi K, Shimohakamada Y et al. Single-institute comparative analysis of unrelated bone marrow transplantation and cord blood transplantation for adult patients with hematologic malignancies. Blood 2004; 104: 3813-3820.
5. Takahashi S, Ooi J, Tomonari A, Konuma T, Tsukada N, Oiwa-Monna M et al. Comparative single-institute analysis of cord blood transplantation from unrelated donors with bone marrow or peripheral blood stem cell transplantation from related donors in adult patients with hematological malignancies after myeloablative conditioning regimen. Blood 2007; 109: 1322-1330.
6. Ooi J, Iseki T, Takahashi S. Tomonari A, Takasugi K, Shimohakamada Y et al. Unrelated cord blood transplantation for adult patients with de novo acute myeloid leukemia. Blood 2004; 103: 489-491.
7. Rubinstein P, Dobrila L, Rosenfield RE, Adamson JW, Migliaccio G, Migliaccio AR et al. Processing and cryopreservation of placental/ umbilical cord blood for unrelated bone marrow reconstitution. Proc Natl Acad Sci USA 1995; 92: 10119-10122.
8. Sauer-Heilborn A, Kadidlo D. McCullough J. Patient care during infusion or hematopoietic progenitor cells. Transfusion 2004; 44: 907-916.
9. Davis JM, Rowley SD, Braine HG, Piantadosi S, Santos GW. Clinical toxicity of cryopreserved bone marrow graft infusion. Blood 1990: 75: 781-786.
10. Zambelli A. Poggi G, Da Prada G, Pedrazzoli P, Cuomo A, Miotti D et al. Clinical toxicity of cryopreserved circulating progenitor cells infusion. Anticancer Res 1998; 18: 4705-4708.
11. Stroncek DF, Fautsch SK, Lasky LC, Hurd DD, Ramsay NK, McCullough J. Adverse reactions in patients transfused with cryopreserved marrow. Transfusion 1991: 31: 521-526.
12. Donmez A, Tombuloglu M, Gungor A, Sover N, Saydam G, Cagirgan S. Clinical side effects during peripheral blood progenitor cell infusion. Transfus Apher Sci 2007; 36: 95-101.
13. Alessandrino P. Bernasconi P, Caldera D, Colombo A, Bonfichi M, Malcovati L et al. Adverse events occurring during bone marrow or peripheral blood progenitor cell infusion: Analysis of 126 cases. Bone Marrow Transplant 1999; 23: 533-537.
14. Milone G, Mercurio S, Strano A, Leotta S, Pinto V, Battiato K et al Adverse events after infusions of cryopreserved hematopoietic stem cells depend on non-mononuclear cells in the infused suspension and patient age. Cytotherapy 2007; 9: 348-355.
15. Styler MJ, Topolsky DL, Crilley PA, Covalesky V, Bryan R, Bulova S et al. Transient high grade heart block following autologous bone marrow infusion. Bone Marrow Transplant 1992; 10: 435-438.
16. Keung YK, Lau S, Elkayam U, Chen SC, Douer D. Cardiac arrhythmia after infusion of cryopreserved stem cells. Bone Marrow Transplant 1994; 14: 361-367.
17. López-Jiménez J, Cerveró C, Muñoz A, Hernández-Madrid A, Fernández Pineda J. García Laraña J et al. Cardiovascular toxicities related to the infusion of cryopreserved grafts: Results of a controlled study. Bone Marrow Transplant 1994; 13: 789-793.
18. Calmels B, Lemarie C, Esterni B, Malugani C, Charbonnier A, Coso D et al. Occurrence and severity of adverse events after autologous hematopoietic progenitor cell infusion are related to the amount of granulocytes in the apheresis product. Transfusion 2007; 47: 1268-1275.
19. Nagamura-Inoue T, Shioya M, Sugo M, Cui Y, Takahashi A, Tomita S et al. Wash-out of DMSO does not improve the speed of engraftment of cord blood transplantatilon: Follow-up of 46 adult patients with units shipped from a single cord blood bank. Transfusion 2003; 43: 1285-1294.
20. Donmez A, Zoghi M, Cagirgan S, Acarlar C, Tombuloglu M. The effect of hematopoietic progenitor cells' temperature on cardiac arrhythmias in patients given peripheral blood progenitor cells. Transfus Apher Sci 2006; 34: 245-251.
21. McKenna DH, Wagner JE, McCullough JJ. Umbilical cord blood infusions are associated with mild reactions and are overall well-tolerated. Cytotherapy 2003; 5: 438 (abstr. 11).
22. Hahn T, Bunworasate U, George MC, Bir AS, Chinratanalab W, Alam AR et al. Use of nonvolume-reduced (unmanipulated after thawing) umbilical cord blood stem cells for allogeneic transplantation results in safe engraftment. Bone Marrow Transplant 2003; 32: 145-150.
23. Petropoulou AD, Bellochine R, Norol F, Marie JP, Rio B. Coronary artery spasm after infusion of cryopreserved cord blood cells. Bone Marrow Transplant 2007; 40: 397-398.
24. Syme R, Bewick M, Stewart D, Porter K, Chadderton T, Glück S. The role of depletion of dimethyl sulfoxide before autografting: On hematologic recovery, side effects, and toxicity. Biol Blood Marrow Transplant 2004; 10: 135-141.